首页> 外国专利> HUMAN HYBRIDOMAS CELL LINES PRODUCING MONOCLONAL ANTIBODIES CAPABLE OF DISTINGUISHING NEOPLASTIC CELLS FROM NORMAL CELLS,ANTIBODIES PRODUCED BY THEM AND METHOD FOR DETERMINING THE PRESENCE OF A NEOPLASM BY USING SAID ANTIBODIES

HUMAN HYBRIDOMAS CELL LINES PRODUCING MONOCLONAL ANTIBODIES CAPABLE OF DISTINGUISHING NEOPLASTIC CELLS FROM NORMAL CELLS,ANTIBODIES PRODUCED BY THEM AND METHOD FOR DETERMINING THE PRESENCE OF A NEOPLASM BY USING SAID ANTIBODIES

机译:产生能够区分正常细胞和正常细胞的单克隆抗体的人血丝细胞株,它们所产生的抗体以及使用所述抗体确定肿瘤存在的方法

摘要

Cells of human cervical tissue suspected of being neoplasmic, such as cervical carcinoma, prostate tumour, lung cancer, etc. are combined in a buffered aq. test medium with mono-clonal anti-bodies capable of distinguishing between normal and neoplasmic cervical cells. The anti-bodies are tagged with a marker capable of giving a detectable signal. Union of the anti-bodies with the human cell tissue is detected by presence of the signal in the test medium. The monoclonal anti-bodies are obtd. from a human hybridoma CLNH5 or CLNH11, or hybridoma derived from these.
机译:将疑似肿瘤的人类宫颈组织细胞(例如宫颈癌,前列腺肿瘤,肺癌等)在缓冲液中合并。带有能够区分正常宫颈细胞和肿瘤宫颈细胞的单克隆抗体的测试培养基。用能够给出可检测信号的标记物标记抗体。通过在测试介质中信号的存在来检测抗体与人细胞组织的结合。单克隆抗体是obtd。来源于人杂交瘤CLNH5或CLNH11,或衍生自这些的杂交瘤。

著录项

  • 公开/公告号IL68752A

    专利类型

  • 公开/公告日1989-06-30

    原文格式PDF

  • 申请/专利权人 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA;

    申请/专利号IL19830068752

  • 发明设计人

    申请日1983-05-22

  • 分类号C12N5/00;C07K15/06;G01N33/53;

  • 国家 IL

  • 入库时间 2022-08-22 06:39:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号